Benchmark: Revised Reviva Pharmaceuticals (RVPH.US) rating and adjusted from Speculative Buy to Specified Buy, target price $17.00.
Benchmark：重申Reviva Pharmaceuticals(RVPH.US)评级，由Speculative Buy调整至Speculative Buy评级, 目标价17.00美元。
Benchmark: Revised Reviva Pharmaceuticals (RVPH.US) rating and adjusted from Speculative Buy to Specified Buy, target price $17.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.